These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30305752)

  • 1. Mouse avatars take off as cancer models.
    Nilsson JA; Olofsson Bagge R; Ny L
    Nature; 2018 Oct; 562(7726):192. PubMed ID: 30305752
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.
    Coral S; Sigalotti L; Covre A; Nicolay HJ; Natali PG; Maio M
    Cancer Res; 2007 Mar; 67(6):2900-1; author reply 2901-2. PubMed ID: 17363616
    [No Abstract]   [Full Text] [Related]  

  • 3. Sorting through the many opportunities for melanoma therapy.
    Herlyn M; Villanueva J
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):975-7. PubMed ID: 21899726
    [No Abstract]   [Full Text] [Related]  

  • 4. CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation model.
    Krepler C; Wacheck V; Strommer S; Hartmann G; Polterauer P; Wolff K; Pehamberger H; Jansen B
    J Invest Dermatol; 2004 Feb; 122(2):387-91. PubMed ID: 15009720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmas for Treating Cancer: Opportunities for Adaptive and Self-Adaptive Approaches.
    Keidar M; Yan D; Beilis II; Trink B; Sherman JH
    Trends Biotechnol; 2018 Jun; 36(6):586-593. PubMed ID: 28755977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.
    Gammaitoni L; Giraudo L; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
    Clin Cancer Res; 2017 May; 23(9):2277-2288. PubMed ID: 27815354
    [No Abstract]   [Full Text] [Related]  

  • 7. Of Mice and Melanoma: PDX System for Modeling Personalized Medicine.
    Hartsough EJ; Aplin AE
    Clin Cancer Res; 2016 Apr; 22(7):1550-2. PubMed ID: 26842234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
    Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
    Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy.
    Ortenberg R; Sapoznik S; Zippel D; Shapira-Frommer R; Itzhaki O; Kubi A; Zikich D; Besser MJ; Schachter J; Markel G
    J Immunol Res; 2015; 2015():902137. PubMed ID: 26688824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
    Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Delivery of OncoVEX
    Moesta AK; Cooke K; Piasecki J; Mitchell P; Rottman JB; Fitzgerald K; Zhan J; Yang B; Le T; Belmontes B; Ikotun OF; Merriam K; Glaus C; Ganley K; Cordover DH; Boden AM; Ponce R; Beers C; Beltran PJ
    Clin Cancer Res; 2017 Oct; 23(20):6190-6202. PubMed ID: 28706012
    [No Abstract]   [Full Text] [Related]  

  • 13. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Researchers push for personalized tumour vaccines.
    Ledford H
    Nature; 2016 Apr; 532(7600):425. PubMed ID: 27121818
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanoma mystery.
    Davis RJ
    Elife; 2017 Jan; 6():. PubMed ID: 28100393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP31, a promising target for the immunotherapy of malignant melanomas.
    Yu S; Wang F; Fan L; Wei Y; Li H; Sun Y; Yang A; Jin B; Song C; Yang K
    J Exp Clin Cancer Res; 2015 Apr; 34(1):36. PubMed ID: 25903101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
    Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.